These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 9635572)
1. Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Miyoshi Y; Iwao K; Nagasawa Y; Aihara T; Sasaki Y; Imaoka S; Murata M; Shimano T; Nakamura Y Cancer Res; 1998 Jun; 58(12):2524-7. PubMed ID: 9635572 [TBL] [Abstract][Full Text] [Related]
2. Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Iwao K; Nakamori S; Kameyama M; Imaoka S; Kinoshita M; Fukui T; Ishiguro S; Nakamura Y; Miyoshi Y Cancer Res; 1998 Mar; 58(5):1021-6. PubMed ID: 9500465 [TBL] [Abstract][Full Text] [Related]
3. Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis. Devereux TR; Anna CH; Foley JF; White CM; Sills RC; Barrett JC Oncogene; 1999 Aug; 18(33):4726-33. PubMed ID: 10467420 [TBL] [Abstract][Full Text] [Related]
4. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis. Miyoshi Y; Iwao K; Nawa G; Yoshikawa H; Ochi T; Nakamura Y Oncol Res; 1998; 10(11-12):591-4. PubMed ID: 10367940 [TBL] [Abstract][Full Text] [Related]
5. Beta-catenin and cyclin D1 expression in human hepatocellular carcinoma. Ueta T; Ikeguchi M; Hirooka Y; Kaibara N; Terada T Oncol Rep; 2002; 9(6):1197-203. PubMed ID: 12375019 [TBL] [Abstract][Full Text] [Related]
6. Molecular and biological analysis of carcinoma of the small intestine: beta-catenin gene mutation by interstitial deletion involving exon 3 and replication error phenotype. Murata M; Iwao K; Miyoshi Y; Nagasawa Y; Ohta T; Shibata K; Oda K; Wada H; Tominaga S; Matsuda Y; Ohsawa M; Nakamura Y; Shimano T Am J Gastroenterol; 2000 Jun; 95(6):1576-80. PubMed ID: 10894600 [TBL] [Abstract][Full Text] [Related]
7. Beta-catenin mutations are frequent in hepatocellular carcinomas but absent in adenomas induced by diethylnitrosamine in B6C3F1 mice. Ogawa K; Yamada Y; Kishibe K; Ishizaki K; Tokusashi Y Cancer Res; 1999 Apr; 59(8):1830-3. PubMed ID: 10213486 [TBL] [Abstract][Full Text] [Related]
8. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426 [TBL] [Abstract][Full Text] [Related]
9. [Mutation analysis of the beta-catenin gene in epithelial carcinomas of the ovaries]. Tanyi J; Páy A; Rigó J; Nagy B; Papp Z Orv Hetil; 2000 May; 141(21):1115-9. PubMed ID: 10876313 [TBL] [Abstract][Full Text] [Related]
10. Beta-catenin accumulation and mutation of exon 3 of the beta-catenin gene in hepatocellular carcinoma. Jpn J Cancer Res; 1999 Dec; 90(12):inside front cover. PubMed ID: 10665642 [No Abstract] [Full Text] [Related]
11. Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Mirabelli-Primdahl L; Gryfe R; Kim H; Millar A; Luceri C; Dale D; Holowaty E; Bapat B; Gallinger S; Redston M Cancer Res; 1999 Jul; 59(14):3346-51. PubMed ID: 10416591 [TBL] [Abstract][Full Text] [Related]
12. Beta-catenin mutations in human prostate cancer. Voeller HJ; Truica CI; Gelmann EP Cancer Res; 1998 Jun; 58(12):2520-3. PubMed ID: 9635571 [TBL] [Abstract][Full Text] [Related]
13. Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene. Xu B; Yoshimoto K; Miyauchi A; Kuma S; Mizusawa N; Hirokawa M; Sano T J Pathol; 2003 Jan; 199(1):58-67. PubMed ID: 12474227 [TBL] [Abstract][Full Text] [Related]
14. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas. Wei Y; Fabre M; Branchereau S; Gauthier F; Perilongo G; Buendia MA Oncogene; 2000 Jan; 19(4):498-504. PubMed ID: 10698519 [TBL] [Abstract][Full Text] [Related]
15. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia. Chen YW; Jeng YM; Yeh SH; Chen PJ Hepatology; 2002 Oct; 36(4 Pt 1):927-35. PubMed ID: 12297840 [TBL] [Abstract][Full Text] [Related]
16. Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver. Kim Y; Sills RC; Houle CD Toxicol Pathol; 2005; 33(1):175-80. PubMed ID: 15805069 [TBL] [Abstract][Full Text] [Related]
17. Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion. Shigemitsu K; Sekido Y; Usami N; Mori S; Sato M; Horio Y; Hasegawa Y; Bader SA; Gazdar AF; Minna JD; Hida T; Yoshioka H; Imaizumi M; Ueda Y; Takahashi M; Shimokata K Oncogene; 2001 Jul; 20(31):4249-57. PubMed ID: 11464291 [TBL] [Abstract][Full Text] [Related]
18. Beta-catenin mutation in carcinoma of the uterine endometrium. Fukuchi T; Sakamoto M; Tsuda H; Maruyama K; Nozawa S; Hirohashi S Cancer Res; 1998 Aug; 58(16):3526-8. PubMed ID: 9721853 [TBL] [Abstract][Full Text] [Related]
19. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features. Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas. Ishizaki Y; Ikeda S; Fujimori M; Shimizu Y; Kurihara T; Itamoto T; Kikuchi A; Okajima M; Asahara T Int J Oncol; 2004 May; 24(5):1077-83. PubMed ID: 15067328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]